CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Quality Index
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €5.83 Billion exceeds net income of €3.88 Billion, indicating high earnings quality where cash backs reported profits. Also explore CVGU asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC PHARMACEUT.GR. ADR4 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CVGU tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year earnings quality comparison for CSPC PHARMACEUT.GR. ADR4. For live market cap and the full company financial profile, see CSPC PHARMACEUT.GR. ADR4 market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | — |